To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Lion dishes up $1.9bn Weetabix partial exit
In the latest example of cross-border investment, London-based Lion has sold a controlling stake in UK-based Weetabix to a Chinese state-run enterprise.
